Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Physical activity, dietary intake (micronutrients and macronutrients) and time spent out door showed no significant statistical difference within the groups before and after the intervention.Baseline characteristics of the participants by groupCharacteristicPlacebo group (n = 42)Omega 3 group (n = 42)Vitamin D group (n = 42)Vitamin D + Omega 3 group (n = 42)P value¶Age (years)41.85 (7.48)39.78 (6.88)39.92 (6.04)39.00 (7.68)0.29Vitamin D25.47 (5.83)23.56 (6.42)21.43(8)22.03 (6.92).44FBS (mg/dL)104.52 (6.39)103.87 (5.88)103.74 (5.11)103.71 (4.73).98Insulin (µIU/mL)7.36 (4.12)9.14 (3.14)7.73 (3.66)10.35 (3.13).30Triglycerides (mg/dL)123.69 (48.17)132.10 (66.77)126.68 (77.7)137.42 (67.02).77Total cholesterol (mg/dL)188.59 (32.82)194.05 (32.4)197.73 (37.8)199.35 (42.11).40HDL-c (mg/dL)48.43 (8.76)51.08 (8.91)51.73 (11.47)48.55 (8.92).34LDL-c (mg/dL)111 (30.74)115.36 (26.91)119.15 (32.71)122.76 (36.47).40Weight (kg)74.32 (12.65)69.65 (9.09)72.80 (9.23)72.54 (10.62).24BMI (kg/m2)27.28 (2.74)27.17 (2.74)27.01 (2.91)27.04 (2.86).82Waist circumference (cm)85.05 (10.42)82.78 (6.41)84.6 (8.49)85.29 (9.85).62Dietary energy intake (kcal)1639.0 (601.9)1645.5 (451.8)1523 (499.6)1570.60 (509.8).26Physical activity (MET-min/week)698.19 (618.83)815.34 (778.54)706.78 (656.76)808.66 (766.99).85Time spent out door (h/day)1.7 (1.8)1.8 (1.2)1.8 (1.4)1.8 (1.8).88BMI: Body Mass Index; FBS: Fasting blood sugar; HDL-C: High-density lipoprotein cholesterol; HOMA-IR: Homeostasis Model Assessment estimated Insulin Resistance; HOMA-B: homeostatic model assessment for B-cell function-B; LDL-C: Low-density lipoprotein cholesterolAll values are means (SDs)*P value is significant¶ Obtain from One-way analysis of variance

Source: Subject characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Randomised controlled trial.

Randomised controlled trial

Assigns participants or groups to comparison interventions by chance.

Meta-analysis unclear · Triple-blind reported · Human research reported

Reported blinded roles: participants.

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The effect of omega-3 and vitamin D co-supplementation on glycemic control and lipid profiles in reproductive-aged women with pre-diabetes and hypovitaminosis D: a randomized controlled trial

Source: Article title.

The present factorial, triple-blind, clinical trial was conducted on 168 women of reproductive age with prediabetes and hypovitaminosis D.

Source: Abstract.

The participants were assigned to four groups based on block randomization method: the placebo group received omega-3 and vitamin D placebos; the omega-3 group took omega-3 supplements and vitamin D placebos; the vitamin D group received omega-3 placebos and vitamin D supplements and the co-supplementation group.

Source: Abstract.

In addition, the packages were identified with the letters A, B, C and D and the researcher, participants and statistician were blinded to their content.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The effect of omega-3 and vitamin D co-supplementation on glycemic control and lipid profiles in reproductive-aged women with pre-diabetes and hypovitaminosis D: a randomized controlled trial

Randomised controlled trial · Diabetology & Metabolic Syndrome · 2020

Original publication title

The effect of omega-3 and vitamin D co-supplementation on glycemic control and lipid profiles in reproductive-aged women with pre-diabetes and hypovitaminosis D: a randomized controlled trial

Masoumeh Rajabi-Naeeni; Mahrokh Dolatian; Mostafa Qorbani; Amir Abbas Vaezi

© The Author(s) 2020

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Vitamin D and omega-3 co-supplementation improved fasting serum glucose, insulin, high-density lipoprotein-cholesterol level, homeostasis model assessment-beta cell function, weight and waist circumference in women of reproductive age with prediabetes and hypovitaminosis D. This co-supplementation can therefore be recommended for glycemic control in these women.

Trial registration Iranian Registry of Clinical Trials Code: IRCT20100130003226N17. Registered on 9 Feb. 2019

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Prediabetes can predispose the individual to type 2 diabetes in the long-term. The present study was conducted to determine the effectiveness of vitamin D and omega-3 co-supplementation on glycemic control and serum lipid profiles in women of reproductive age with prediabetes and hypovitaminosis D.

Source: Background

Abstract: What methods does the paper describe?

The present factorial, triple-blind, clinical trial was conducted on 168 women of reproductive age with prediabetes and hypovitaminosis D. The participants were assigned to four groups based on block randomization method: the placebo group received omega-3 and vitamin D placebos; the omega-3 group took omega-3 supplements and vitamin D placebos; the vitamin D group received omega-3 placebos and vitamin D supplements and the co-supplementation group. The groups received every 2 weeks 50,000 IU pearls of vitamin D and twice-daily doses of 1000-mg omega-3 tablets or placebos for 8 weeks.

Dietary intake, physical activity, anthropometric indices and blood biochemical tests were measured at the beginning and end of the study. Analysis was performed using two-way mixed ANOVA.

Source: Methods

Abstract: Results

A significant reduction was observed in fasting glucose, insulin, homeostasis model assessment-beta cell function, weight and waist circumference in the co-supplementation group compared to the other three groups (P < 0.05). Moreover, high-density lipoprotein-cholesterol levels increased significantly in the co-supplementation group compared to the other three groups (P < 0.05). Despite the fact that homeostasis model assessment-insulin resistance, total cholesterol, triglyceride and low-density lipoprotein-cholesterol levels decreased after intervention in the co-supplementation group, there was no significant difference between the groups in these outcomes.

Source: Results

Abstract: Conclusion

Vitamin D and omega-3 co-supplementation improved fasting serum glucose, insulin, high-density lipoprotein-cholesterol level, homeostasis model assessment-beta cell function, weight and waist circumference in women of reproductive age with prediabetes and hypovitaminosis D. This co-supplementation can therefore be recommended for glycemic control in these women.

Trial registration Iranian Registry of Clinical Trials Code: IRCT20100130003226N17. Registered on 9 Feb. 2019

Source: Conclusion Source: Conclusion
Authors’ abstract

Background

Prediabetes can predispose the individual to type 2 diabetes in the long-term. The present study was conducted to determine the effectiveness of vitamin D and omega-3 co-supplementation on glycemic control and serum lipid profiles in women of reproductive age with prediabetes and hypovitaminosis D.

Methods

The present factorial, triple-blind, clinical trial was conducted on 168 women of reproductive age with prediabetes and hypovitaminosis D. The participants were assigned to four groups based on block randomization method: the placebo group received omega-3 and vitamin D placebos; the omega-3 group took omega-3 supplements and vitamin D placebos; the vitamin D group received omega-3 placebos and vitamin D supplements and the co-supplementation group. The groups received every 2 weeks 50,000 IU pearls of vitamin D and twice-daily doses of 1000-mg omega-3 tablets or placebos for 8 weeks.

Dietary intake, physical activity, anthropometric indices and blood biochemical tests were measured at the beginning and end of the study. Analysis was performed using two-way mixed ANOVA.

Results

A significant reduction was observed in fasting glucose, insulin, homeostasis model assessment-beta cell function, weight and waist circumference in the co-supplementation group compared to the other three groups (P < 0.05). Moreover, high-density lipoprotein-cholesterol levels increased significantly in the co-supplementation group compared to the other three groups (P < 0.05). Despite the fact that homeostasis model assessment-insulin resistance, total cholesterol, triglyceride and low-density lipoprotein-cholesterol levels decreased after intervention in the co-supplementation group, there was no significant difference between the groups in these outcomes.

Conclusion

Vitamin D and omega-3 co-supplementation improved fasting serum glucose, insulin, high-density lipoprotein-cholesterol level, homeostasis model assessment-beta cell function, weight and waist circumference in women of reproductive age with prediabetes and hypovitaminosis D. This co-supplementation can therefore be recommended for glycemic control in these women.

Trial registration Iranian Registry of Clinical Trials Code: IRCT20100130003226N17. Registered on 9 Feb. 2019

Publication and source details

Original title: The effect of omega-3 and vitamin D co-supplementation on glycemic control and lipid profiles in reproductive-aged women with pre-diabetes and hypovitaminosis D: a randomized controlled trial

Masoumeh Rajabi-Naeeni; Mahrokh Dolatian; Mostafa Qorbani; Amir Abbas Vaezi

Diabetology & Metabolic Syndrome · 2020

© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/501100005851Shahid Beheshti University of Medical Sciences312/9132Dolatian Mahrokh

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T17:22:49.224190+00:00

DOI: 10.1186/s13098-020-00549-9 · PMC7218636